Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.64 |
| ▸ | CA1 | P00915 | 2/20 | 0.64 |
| ▸ | CA2 | P00918 | 2/20 | 0.64 |
| ▸ | CA4 | P22748 | 2/20 | 0.64 |
| ▸ | CA5A | P35218 | 2/20 | 0.64 |
| ▸ | CA7 | P43166 | 2/20 | 0.64 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.64 |
| ▸ | LGALS3 | P17931 | 9/20 | 0.54 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.53 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.51 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.51 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17468111 | 1.00 | CA12 (0.64) | CA12CA1CA2CA4CA5A | |
| SCHEMBL3824089 | 1.00 | CA12 (0.64) | CA12CA1CA2CA4CA5A | |
| SCHEMBL2163405 | 1.00 | CA12 (0.64) | CA12CA1CA2CA4CA5A | |
| SCHEMBL17680214 | 1.00 | CA12 (0.64) | CA12CA1CA2CA4CA5A | |
| SCHEMBL19818850 | 1.00 | CA12 (0.64) | CA12CA1CA2CA4CA5A | |
| SCHEMBL17683647 | 1.00 | CA12 (0.64) | CA12CA1CA2CA4CA5A | |
| SCHEMBL15239502 | 0.98 | CA12 (0.62) | CA12CA1CA2CA4CA5A | |
| SCHEMBL5324450 | 0.98 | CA12 (0.62) | CA12CA1CA2CA4CA5A | |
| SCHEMBL5324452 | 0.98 | CA12 (0.62) | CA12CA1CA2CA4CA5A | |
| SCHEMBL18461439 | 0.88 | CA12 (0.50) | CA12CA1CA2CA4CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007128480-A2 | THIOGLYCOSIDES AS PHARMACEUTICALLY ACTIVE AGENTS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2007-11-15 | — | — | WO | claimed |
| CN-114085255-B | Cronobacter cloacae 5-lipopolysaccharide O-antigen oligosaccharide fragment and preparation method and application thereof | 山东大学 | 2023-08-29 | — | — | CN | disclosed |
| CN-114085255-A | Cronobacter zuchendii type 5 lipopolysaccharide O-antigen oligosaccharide fragment and preparation method and application thereof | 山东大学 | 2022-02-25 | — | — | CN | disclosed |
| US-20150344513-A9 | METHODS AND INTERMEDIATES FOR THE PREPARATION OF FONDAPARINUX | ACADEMIA SINICA (TW) | 2015-12-03 | — | — | US | disclosed |
| US-20150126721-A1 | METHODS AND INTERMEDIATES FOR THE PREPARATION OF FONDAPARINUX | ACADEMIA SINICA (TW) | 2015-05-07 | — | — | US | disclosed |
| US-8912149-B1 | Glycosaminoglycan mimetics | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2014-12-16 | — | — | US | disclosed |
| US-8338387-B2 | Small molecule stimulators of neuronal growth | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2012-12-25 | — | — | US | disclosed |
| US-20100075920-A1 | SMALL MOLECULE STIMULATORS OF NEURONAL GROWTH | NATIONAL SCIENCE FOUNDATION | 2010-03-25 | — | — | US | disclosed |
| US-7638503-B2 | Small molecule stimulators of neuronal growth | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2009-12-29 | — | — | US | disclosed |
| WO-2007128480-A2 | THIOGLYCOSIDES AS PHARMACEUTICALLY ACTIVE AGENTS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2007-11-15 | — | — | WO | disclosed |
| EP-1854806-A1 | Thioglycosides as pharmaceutically active agents | MPG Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2007-11-14 | — | — | EP | disclosed |
| EP-1761550-A2 | SMALL MOLECULE STIMULATORS OF NEURONAL GROWTH | California Institute of Technology (US) | 2007-03-14 | — | — | EP | disclosed |
| US-20060025379-A1 | Small molecule stimulators of neuronal growth | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2006-02-02 | — | — | US | disclosed |
| WO-2005118609-A2 | SMALL MOLECULE STIMULATORS OF NEURONAL GROWTH | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2005-12-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150344513-A9 | METHODS AND INTERMEDIATES FOR THE PREPARATION OF FONDAPARINUX | F2, TBXA2R, PROC | CA12 975/4885CA1 670/4885CA2 839/4885 |
| US-20060025379-A1 | Small molecule stimulators of neuronal growth | BDNF, GAP43, NGF | CA12 3450/4885CA1 1018/4885CA2 1634/4885 |
| US-20100075920-A1 | SMALL MOLECULE STIMULATORS OF NEURONAL GROWTH | BDNF, GAP43, NGF | CA12 3450/4885CA1 1018/4885CA2 1634/4885 |
| US-20150126721-A1 | METHODS AND INTERMEDIATES FOR THE PREPARATION OF FONDAPARINUX | F2, TBXA2R, PROC | CA12 975/4885CA1 670/4885CA2 839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.